Cours Mabvax Therapeutics Holdings Inc Nasdaq
Actions
US55414P5044
Recherche biotechnologique et médicale
CA 2016 | 148 k 134 k | CA 2017 | - | Capitalisation | 14,41 M 13,07 M |
---|---|---|---|---|---|
Résultat net 2016 | -17 M -15,42 M | Résultat net 2017 | -19 M -17,23 M | VE / CA 2016 | 147 x |
Dette nette 2016 | 470 k 426 k | Dette nette 2017 | 2,48 M 2,25 M | VE / CA 2017 | - |
PER 2016 |
-0,93
x | PER 2017 |
-0,25
x | Employés | - |
Rendement 2016 * |
-
| Rendement 2017 |
-
| Flottant | 92,02% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+8,29% | 113 Md | |
+10,21% | 106 Md | |
+0,41% | 22,27 Md | |
-11,90% | 22,22 Md | |
-5,99% | 19,43 Md | |
-37,36% | 17,87 Md | |
-5,17% | 17,24 Md | |
+7,70% | 14,29 Md | |
+37,65% | 12,52 Md |